CIK 0000034956
- Non-accelerated filer
- Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262593535
- Phone
- +1 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 4 Open-market buy 10% owner bought 34,903 shares at an average $1.51 ($52,700)
- 4 Open-market buy Director bought 311,481 shares at an average $1.48 ($460,443)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 5,000 shares at $0.95 ($4,774)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Returned to the company CFO returned 5,720 shares (to the company)
- 4 Returned to the company CFO returned 6,425 shares (to the company)
- 4 Returned to the company CFO returned 98 shares (to the company)
- 4 Open-market buy Director bought 12,950 shares at an average $0.45 ($5,887)
Page 5 of 11 · 206 filings